About this episode
Occidental Petroleum will buy CrownRock for $12 billion, deepening its foothold in the Permian basin. Energy expert and author of “The New Map: Energy, Climate and the Clash of Nations” Daniel Yergin explains what the recent flurry of oil industry mergers means for geopolitics. The FDA has approved treatment for sickle cell disease , the first treatment to use the gene-editing tool CRISPR. Former FDA Commissioner Dr. Scott Gottlieb discusses a treatment’s journey from lab to patients, as well as improving the public’s access to life-saving care. Plus, Macy’s has a $5.8 billion buyout offer , and University of Pennsylvania’s President Elizabeth Magill has resigned after her controversial testimony on Capitol Hill last week . Daniel Yergin - 15:38 Dr. Scott Gottlieb - 23:50 In this episode: Dan Yergin, @danielyergin Scott Gottlieb, @ScottGottliebMD Michael Santoli, @michaelsantoli Andrew Ross Sorkin, @andrewrsorkin Becky Quick, @BeckyQuick Katie Kramer, @Kramer_Katie Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.